-
Je něco špatně v tomto záznamu ?
Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128
K. Musilek, J. Roder, M. Komloova, O. Holas, M. Hrabinova, M. Pohanka, V. Dohnal, V. Opletalova, K. Kuca, YS. Jung
Bioorganic & medicinal chemistry letters.
2011 ;
21 (1) :
150-154.
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Perzistentní odkaz
https://www.medvik.cz/link/bmc12027230
- MeSH
- acetylcholinesterasa chemie metabolismus MeSH
- cholinesterasové inhibitory chemická syntéza chemie farmakologie MeSH
- katalytická doména MeSH
- molekulární modely MeSH
- organofosfáty chemie MeSH
- počítačová simulace MeSH
- pyridinové sloučeniny chemická syntéza chemie farmakologie MeSH
- vazebná místa MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Carbamate inhibitors (e.g., pyridostimine bromide) are used as a pre-exposure treatment for the prevention of organophosphorus poisoning. They work by blocking acetylcholinesterase's (AChE) native function and thus protect AChE against irreversible inhibition by organophosphorus compounds. However, carbamate inhibitors are known for many undesirable side-effects related to the carbamylation of AChE. In this Letter, 19 analogues of SAD-128 were prepared and evaluated as cholinesterase inhibitors. The screening results showed promising inhibitory ability of four compounds better to used standards (pralidoxime, obidoxime, BW284c51, ethopropazine, SAD-128). Four most promising compounds were selected for further molecular docking studies. The SAR was stated from obtained data. The former receptor studies were reported and discussed. The further in vivo studies were recommended in the view of OP pre-exposure treatment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027230
- 003
- CZ-PrNML
- 005
- 20160329165155.0
- 007
- ta
- 008
- 120816s2011 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bmcl.2010.11.051 $2 doi
- 035 __
- $a (PubMed)21144749
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Musílek, Kamil, $u University of Defence, Faculty of Military Health Sciences, Department of Toxicology, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University of Jan Evangelista Purkynje, Faculty of Science, Department of Chemistry, Ceske mladeze 8, 400 96 Usti nad Labem, Czech Republic $d 1980- $7 xx0135628
- 245 10
- $a Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128 / $c K. Musilek, J. Roder, M. Komloova, O. Holas, M. Hrabinova, M. Pohanka, V. Dohnal, V. Opletalova, K. Kuca, YS. Jung
- 520 9_
- $a Carbamate inhibitors (e.g., pyridostimine bromide) are used as a pre-exposure treatment for the prevention of organophosphorus poisoning. They work by blocking acetylcholinesterase's (AChE) native function and thus protect AChE against irreversible inhibition by organophosphorus compounds. However, carbamate inhibitors are known for many undesirable side-effects related to the carbamylation of AChE. In this Letter, 19 analogues of SAD-128 were prepared and evaluated as cholinesterase inhibitors. The screening results showed promising inhibitory ability of four compounds better to used standards (pralidoxime, obidoxime, BW284c51, ethopropazine, SAD-128). Four most promising compounds were selected for further molecular docking studies. The SAR was stated from obtained data. The former receptor studies were reported and discussed. The further in vivo studies were recommended in the view of OP pre-exposure treatment.
- 650 _2
- $a acetylcholinesterasa $x chemie $x metabolismus $7 D000110
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a cholinesterasové inhibitory $x chemická syntéza $x chemie $x farmakologie $7 D002800
- 650 _2
- $a počítačová simulace $7 D003198
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a organofosfáty $x chemie $7 D010755
- 650 _2
- $a pyridinové sloučeniny $x chemická syntéza $x chemie $x farmakologie $7 D011726
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Roder, Jan $u Charles University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry and Drug Control, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Komloová, Markéta $7 _AN050034 $u Charles University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry and Drug Control, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Holas, Ondřej $7 xx0128555 $u Charles University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry and Drug Control, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Hrabinová, Martina $7 xx0118798 $u University of Defence, Faculty of Military Health Sciences, Centre of Advanced Studies, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic
- 700 1_
- $a Pohanka, Miroslav $7 hka2010563580 $u University of Defence, Faculty of Military Health Sciences, Centre of Advanced Studies, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic
- 700 1_
- $a Dohnal, Vlastimil $7 pna2015873045 $u University of Jan Evangelista Purkynje, Faculty of Science, Department of Chemistry, Ceske mladeze 8, 400 96 Usti nad Labem, Czech Republic
- 700 1_
- $a Opletalová, Veronika, $d 1955- $7 jn20000620259 $u Charles University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry and Drug Control, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Kuča, Kamil, $d 1978- $7 xx0041831 $u University of Defence, Faculty of Military Health Sciences, Centre of Advanced Studies, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic; University of Jan Evangelista Purkynje, Faculty of Science, Department of Chemistry, Ceske mladeze 8, 400 96 Usti nad Labem, Czech Republic
- 700 1_
- $a Jung, Young-Sik $u Bioorganic Science Division, Korea Research Institute of Chemical Technology, PO Box 107, Yuseong, Daejeon 305-606, Republic of Korea
- 773 0_
- $w MED00000770 $t Bioorganic & medicinal chemistry letters $x 1464-3405 $g Roč. 21, č. 1 (2011), s. 150-154
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21144749 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160329164917 $b ABA008
- 999 __
- $a ok $b bmc $g 949272 $s 784576
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 21 $c 1 $d 150-154 $i 1464-3405 $m Bioorganic & medicinal chemistry letters $n Bioorg Med Chem Lett $x MED00000770
- LZP __
- $b NLK112 $a Pubmed-20120816/11/02
